68 related articles for article (PubMed ID: 1975829)
1. Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response.
Chakraborty NG; Twardzik DR; Sivanandham M; Ergin MT; Hellstrom KE; Mukherji B
J Immunol; 1990 Oct; 145(7):2359-64. PubMed ID: 1975829
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
Mukherji B; Nashed AL; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
Mukherji B; Wilhelm SA; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer.
Mukherji B; Guha A; Loomis R; Ergin MT
J Immunol; 1987 Mar; 138(6):1987-91. PubMed ID: 2950174
[TBL] [Abstract][Full Text] [Related]
5. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells.
Yang TH; Aosai F; Norose K; Ueda M; Yano A
J Immunol; 1995 Jan; 154(1):290-8. PubMed ID: 7995948
[TBL] [Abstract][Full Text] [Related]
7. Classification of CD4+ T helper cell clones in human melanoma.
Goedegebuure PS; Lee KY; Matory YL; Peoples GE; Yoshino I; Eberlein TJ
Cell Immunol; 1994 Jun; 156(1):170-9. PubMed ID: 7911074
[TBL] [Abstract][Full Text] [Related]
8. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
[TBL] [Abstract][Full Text] [Related]
9. Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.
Dufour E; Carcelain G; Gaudin C; Flament C; Avril MF; Faure F
J Immunol; 1997 Apr; 158(8):3787-95. PubMed ID: 9103444
[TBL] [Abstract][Full Text] [Related]
10. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta.
Somasundaram R; Jacob L; Swoboda R; Caputo L; Song H; Basak S; Monos D; Peritt D; Marincola F; Cai D; Birebent B; Bloome E; Kim J; Berencsi K; Mastrangelo M; Herlyn D
Cancer Res; 2002 Sep; 62(18):5267-72. PubMed ID: 12234995
[TBL] [Abstract][Full Text] [Related]
12. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
[TBL] [Abstract][Full Text] [Related]
13. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
14. Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines.
Chakraborty NG; Li L; Sporn JR; Kurtzman SH; Ergin MT; Mukherji B
J Immunol; 1999 May; 162(9):5576-83. PubMed ID: 10228040
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
Itoh K; Tilden AB; Balch CM
Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma.
Chakraborty NG; Chattopadhyay S; Mehrotra S; Chhabra A; Mukherji B
Hum Immunol; 2004 Aug; 65(8):794-802. PubMed ID: 15336780
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
18. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
19. Suppressor function of lymphocytes activated in in vitro co-culture against autologous tumor cells and expanded in interleukin-2.
Okino T; Chakraborty NG; Ergin MT; Mukherji B
In Vivo; 1991; 5(6):631-5. PubMed ID: 1687355
[TBL] [Abstract][Full Text] [Related]
20. IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response.
Guarini A; Gansbacher B; Cronin K; Fierro MT; Foa R
Cytokines Mol Ther; 1995 Mar; 1(1):57-64. PubMed ID: 9384664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]